Evidence map›Paper›PMID 38398766›Full record

ArticleLife (Basel, Switzerland)2024

Multifocality in Testicular Cancer: Clinicopathological Correlations and Prognostic Implications.

Uros Bumbasirevic, Milos Petrovic, Milica Zekovic, Vesna Coric, Bogomir Milojevic, Nikola Lisicic, David Obucina, Nenad Vasilic, Petar Bulat, Marko Zivkovic and 3 more

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Uros BumbasirevicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-0367-2745
Milos PetrovicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-9490-1197
Milica ZekovicCentre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-2597-3426
Vesna CoricInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-0227-821X
Bogomir MilojevicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-6784-8389
Nikola LisicicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
David ObucinaClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Nenad VasilicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-0870-5585
Petar BulatClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-6385-5116
Marko ZivkovicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Milica CekerevacDepartment of Pathology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.
Nebojsa BojanicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-7616-507X
Aleksandar JanicicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
University of Belgrade · RSUniverzitetski Klinički Centar Srbije · RS

Funding

Wellcome Trust 200110
6 · The paper itself

Abstract

There are limited data regarding the significance of multifocality in testicular cancer patients. This study evaluated the relationship between multifocality and clinicopathological features determined at the time of radical orchiectomy. The study involved 280 consecutive patients who underwent radical orchiectomy between 2018 and 2023. Multifocality was defined as a distinct tumor focus characterized by a group of malignant cells > 1 mm, clearly differentiated from the primary tumor mass. Uni- and multivariate logistic regression analyses were employed to investigate the association between multifocality and histopathological parameters along with potential risk factors for clinical stages II + III. Multifocality was identified in 44 (15.7%) patients. Significantly smaller primary tumors were observed in subjects with multifocality (20.0 mm vs. 30.0 mm,

Indexed as

multifocalityprognostic factorstesticular cancertesticular GCT

Identifiers

PMID38398766
PMCPMC10890071
OpenAlexW4391883207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.